EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieKohortenstudieOpen Access · CC BY 4.0

Serum neurofilament light chain associates with symptom burden in Lyme neuroborreliosis patients: a longitudinal cohort study from Norway

Ingerid Skarstein, Elling Ulvestad, Anne Marit Solheim, Christian Vedeler, Unn Ljøstad, Åse Mygland, Randi Eikeland, Harald Reiso, Åslaug Rudjord Lorentzen, Steffan Daniel Bos

Journal of Neurology · 2024

DOI: 10.1007/s00415-024-12237-z ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Neurology, 2024. Verfasst von Ingerid Skarstein und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Haukeland University Hospital, Post Box 1400, 5021, Bergen, Norway. Ingerid.skarstein@helse-bergen.no. Hauptthemen laut MEDLINE: Lyme Neuroborreliosis, Neurofilament Proteins, Biomarkers. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Helse Vest, University of Bergen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Serum neurofilament light chain (sNfL), an indicator of neuronal damage, is increasingly recognized as a potential biomarker for disease activity in neurodegenerative disorders. In this study, we wanted to investigate sNfL as a prognostic marker in a large, well-defined population of 90 patients with Lyme neuroborreliosis (LNB). In addition, we sought to explore associations between symptoms and sNfL levels during the acute phase of LNB. Materials and methods Patients diagnosed with definite or possible LNB were recruited from a double-blinded, placebo-controlled, multi-center trial, in which the participants were randomly assigned to 2 or 6 weeks of oral doxycycline treatment. The sNfL levels were measured using a single molecule array assay at both diagnosis and 6-month follow-up, and analysed against clinical parameters, variations in symptom burden and long-term complaints as assessed by a composite clinical score.

Results

At the time of diagnosis, approximately 60% of the patients had elevated sNfL levels adjusted for age. Notably, mean sNfL levels were significantly higher at diagnosis (52 pg/ml) compared to 6 months after treatment (12 pg/ml, p < 0.001), when sNfL levels had normalized in the majority of patients. Patients with objective signs of spinal radiculitis had significantly higher baseline sNfL levels compared to patients without spinal radiculitis ( p = 0.033).

Conclusion

Our findings suggest that sNfL can serve as a biomarker for peripheral nerve tissue involvement in the acute phase of LNB. As found in an earlier study, we confirm normalization of sNfL levels in blood after treatment. We found no prognostic value of acute-phase sNfL levels on patient outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lyme NeuroborreliosisNeurofilament ProteinsBiomarkersHumansMaleFemaleMiddle AgedNorwayAdultAgedLongitudinal StudiesDouble-Blind MethodAnti-Bacterial AgentsDoxycyclineCohort StudiesSymptom Burden

Stichwörter der Autor:innen

Central nervous system infectionsLyme neuroborreliosisNeurofilament light chainTick-borne diseases

Substanzen

Neurofilament Proteinsneurofilament protein LBiomarkersAnti-Bacterial AgentsDoxycycline

Autor:innen und Institutionen

  • Department of Microbiology, Haukeland University Hospital, Post Box 1400, 5021, Bergen, Norway. Ingerid.skarstein@helse-bergen.no.
  • Department of Clinical Science, University of Bergen, Bergen, Norway. Ingerid.skarstein@helse-bergen.no.
  • Department of Microbiology, Haukeland University Hospital, Post Box 1400, 5021, Bergen, Norway.
  • Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Department of Neurology, Sørlandet Hospital Trust, Kristiansand, Norway.
  • Department of Clinical Medicine, University of Bergen, Bergen, Norway.

Förderung

  • Helse Vest
  • University of Bergen

Zitieren

APA

Skarstein, I., Ulvestad, E., Solheim, A. M., Vedeler, C., Ljøstad, U., Mygland, Å., Eikeland, R., Reiso, H., Lorentzen, Å. R., & Bos, S. D. (2024). Serum neurofilament light chain associates with symptom burden in Lyme neuroborreliosis patients: a longitudinal cohort study from Norway. Journal of Neurology. https://doi.org/10.1007/s00415-024-12237-z

Vancouver

Skarstein I, Ulvestad E, Solheim AM, Vedeler C, Ljøstad U, Mygland Å, et al. Serum neurofilament light chain associates with symptom burden in Lyme neuroborreliosis patients: a longitudinal cohort study from Norway. Journal of Neurology. 2024. doi:10.1007/s00415-024-12237-z

BibTeX
@article{Skarstein2024,
  author = {Skarstein, Ingerid and Ulvestad, Elling and Solheim, Anne Marit and Vedeler, Christian and Ljøstad, Unn and Mygland, Åse and Eikeland, Randi and Reiso, Harald and Lorentzen, Åslaug Rudjord and Bos, Steffan Daniel},
  title = {Serum neurofilament light chain associates with symptom burden in Lyme neuroborreliosis patients: a longitudinal cohort study from Norway},
  journal = {Journal of Neurology},
  year = {2024},
  doi = {10.1007/s00415-024-12237-z}
}
Kostenlos starten →